The CDMO is reworking its small-scale business unit after a lack of investment into early-stage cell and gene therapy research projects.
Fujifilm plots another $1.2B expansion, hiring spree at NC site
Fujifilm secures J&J as first tenant at $2bn Holly Springs plant
Fast on the heels of naming a new chief executive earlier this summer, Fujifilm Diosynth Biotechnologies said it's rolling out a new business structure to support customers of various sizes.
Last week saw a change at the top for the contract manufacturer Fujifilm Diosynth Biotechnologies, with Lars Petersen replacing Martin Meeson as president and CEO.
Fujifilm Diosynth Biotechnologies, the CDMO arm of the Japanese conglomerate Fujifilm, appointed Lars Petersen as president and CEO amid the company’s expansion of its manufacturing business in Europe and the US.
Fujifilm to Enhance Commercial Presence in Asia for Biologics and Advanced Therapies Contract Services
Fujifilm Diosynth Biotechnologies’ Biologics Production Facility Expansion, Hillerod, Denmark
FUJIFILM Diosynth Biotechnologies Acquires Additional 41 Acres of Land in RTP
Fujifilm Diosynth had a busy 2022, investing more than $1 billion into its manufacturing sites while expanding its global footprint.